Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.83 per share versus the Zacks Consensus Estimate of a loss of $0.99. This compares to a loss of $1.24 per share a year ago

NexPoint (NREF) Meets Q4 Earnings Estimates
NexPoint (NREF) Meets Q4 Earnings Estimates

NexPoint (NREF) came out with quarterly earnings of $0.48 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.83 per share a year ago. These figures are adjusted

Novavax (NVAX) Beats Q4 Earnings and Revenue Estimates
Novavax (NVAX) Beats Q4 Earnings and Revenue Estimates

Novavax (NVAX) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.66 per share. This compares to a loss of $0.51 per share a year ago. These

Nomad Foods (NOMD) Q4 Earnings Match Estimates
Nomad Foods (NOMD) Q4 Earnings Match Estimates

Nomad Foods (NOMD) came out with quarterly earnings of $0.5 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.45 per share a year ago. These figures are adjusted

Cheniere Energy (LNG) Misses Q4 Earnings Estimates
Cheniere Energy (LNG) Misses Q4 Earnings Estimates

Cheniere Energy (LNG) came out with quarterly earnings of $2.87 per share, missing the Zacks Consensus Estimate of $3.83 per share. This compares to earnings of $4.33 per share a year ago. These

Nuveen Churchill Direct Lending Corp. (NCDL) Surpasses Q4 Earnings Estimates
Nuveen Churchill Direct Lending Corp. (NCDL) Surpasses Q4 Earnings Estimates

Nuveen Churchill Direct Lending Corp. (NCDL) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.56 per

MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates

MannKind (MNKD) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.03 per share a year ago. These figures are

Middleby (MIDD) Beats Q4 Earnings Estimates
Middleby (MIDD) Beats Q4 Earnings Estimates

Middleby (MIDD) came out with quarterly earnings of $2.42 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.88 per share a year ago. These figures

Marcus (MCS) Reports Q4 Loss, Tops Revenue Estimates
Marcus (MCS) Reports Q4 Loss, Tops Revenue Estimates

Marcus (MCS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.13 per share a year ago. These figures are adjusted for

Hertz Global Holdings, Inc. (HTZ) Reports Q4 Loss, Beats Revenue Estimates
Hertz Global Holdings, Inc. (HTZ) Reports Q4 Loss, Beats Revenue Estimates

Hertz Global Holdings, Inc. (HTZ) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $1.18 per share a year ago

Lindblad Expeditions (LIND) Reports Q4 Loss, Tops Revenue Estimates
Lindblad Expeditions (LIND) Reports Q4 Loss, Tops Revenue Estimates

Lindblad Expeditions (LIND) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.48 per share a year ago. These

Koppers (KOP) Q4 Earnings Surpass Estimates
Koppers (KOP) Q4 Earnings Surpass Estimates

Koppers (KOP) came out with quarterly earnings of $0.7 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.77 per share a year ago. These figures are

Installed Building Products (IBP) Q4 Earnings and Revenues Beat Estimates
Installed Building Products (IBP) Q4 Earnings and Revenues Beat Estimates

Installed Building Products (IBP) came out with quarterly earnings of $3.24 per share, beating the Zacks Consensus Estimate of $2.8 per share. This compares to earnings of $2.9 per share a year ago

Shift4 Payments (FOUR) Q4 Earnings Surpass Estimates
Shift4 Payments (FOUR) Q4 Earnings Surpass Estimates

Shift4 Payments (FOUR) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.35 per share a year ago. These

Emcor Group (EME) Q4 Earnings and Revenues Top Estimates
Emcor Group (EME) Q4 Earnings and Revenues Top Estimates

Emcor Group (EME) came out with quarterly earnings of $7.19 per share, beating the Zacks Consensus Estimate of $6.68 per share. This compares to earnings of $6.32 per share a year ago. These figures

FTI Consulting (FCN) Surpasses Q4 Earnings and Revenue Estimates
FTI Consulting (FCN) Surpasses Q4 Earnings and Revenue Estimates

FTI Consulting (FCN) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.56 per share a year ago. These

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $2.04 per share, missing the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $1.77 per share a year ago

Cars.com (CARS) Misses Q4 Earnings Estimates
Cars.com (CARS) Misses Q4 Earnings Estimates

Cars.com (CARS) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.49 per share a year ago. These figures

CRA International (CRAI) Q4 Earnings and Revenues Beat Estimates
CRA International (CRAI) Q4 Earnings and Revenues Beat Estimates

CRA International (CRAI) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $2.03 per share a year ago. These

Burford Capital Limited (BUR) Reports Q4 Loss, Misses Revenue Estimates
Burford Capital Limited (BUR) Reports Q4 Loss, Misses Revenue Estimates

Burford Capital Limited (BUR) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of $0.37. This compares to a loss of $0.06 per share a year ago. These figures are

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates
Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika Therapeutics (ANIK) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.03 per share a year ago. These

ACM Research, Inc. (ACMR) Lags Q4 Earnings Estimates
ACM Research, Inc. (ACMR) Lags Q4 Earnings Estimates

ACM Research, Inc. (ACMR) came out with quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.56 per share a year ago. These

BlackSky Technology Inc. (BKSY) Reports Q4 Loss, Lags Revenue Estimates
BlackSky Technology Inc. (BKSY) Reports Q4 Loss, Lags Revenue Estimates

BlackSky Technology Inc. (BKSY) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.39 per share a year ago. These

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to a loss of $0.13 per share a year ago

Why Heritage Insurance (HRTG) Could Beat Earnings Estimates AgainPhoto, wide shot, wide-angle lens,  Reinsurance company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/490045fb-8676-41a9-be7a-bcf4281c7d92.png
Why Heritage Insurance (HRTG) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Heritage Insurance (HRTG), which belongs